$6.94
2.81% yesterday
Nasdaq, Sep 26, 10:10 pm CET
ISIN
US8269171067
Symbol
SIGA

SIGA Technologies Inc Stock price

$6.94
-2.47 26.25% 1M
-1.38 16.59% 6M
+1.72 33.04% YTD
+2.26 48.41% 1Y
+1.11 19.03% 3Y
+2.68 62.85% 5Y
+5.82 517.44% 10Y
Nasdaq, Closing price Thu, Sep 26 2024
+0.19 2.81%
ISIN
US8269171067
Symbol
SIGA

Key metrics

Market capitalization $481.74m
Enterprise Value $376.41m
P/E (TTM) P/E ratio 5.72
EV/FCF (TTM) EV/FCF 5.10
EV/Sales (TTM) EV/Sales 2.18
P/S ratio (TTM) P/S ratio 2.79
P/B ratio (TTM) P/B ratio 2.87
Dividend yield 0.00%
Last dividend (FY23) $0.42
Revenue growth (TTM) Revenue growth 76.90%
Revenue (TTM) Revenue $172.96m
EBIT (operating result TTM) EBIT $102.72m
Free Cash Flow (TTM) Free Cash Flow $73.77m
Cash position $106.95m
EPS (TTM) EPS $1.18
P/E forward 6.68
P/S forward 3.00
EV/Sales forward 2.35
Short interest 11.14%
Show more

Is SIGA Technologies Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,900 stocks worldwide.

SIGA Technologies Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast SIGA Technologies Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast SIGA Technologies Inc:

Buy
100%

Financial data from SIGA Technologies Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
173 173
77% 77%
100%
- Direct Costs 31 31
349% 349%
18%
142 142
56% 56%
82%
- Selling and Administrative Expenses 26 26
22% 22%
15%
- Research and Development Expense 12 12
45% 45%
7%
103 103
196% 196%
60%
- Depreciation and Amortization 0.55 0.55
4% 4%
0%
EBIT (Operating Income) EBIT 103 103
199% 199%
59%
Net Profit 84 84
195% 195%
49%

In millions USD.

Don't miss a Thing! We will send you all news about SIGA Technologies Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

SIGA Technologies Inc Stock News

Neutral
PRNewsWire
about 12 hours ago
NEW YORK , Sept. 26, 2024 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigating potential securities claims on behalf of purchasers of SIGA Technologies, Inc.(NASDAQ: SIGA) ("SIGA" or the "Company") SIGA Technologies, Inc. operates as a commercial-stage pharmaceutical company.
Neutral
GlobeNewsWire
about one month ago
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in infectious diseases, today announced a new contract with the U.S. Department of Defense (DOD) for the procurement of approximately $9 million of TPOXX® (Contract number: W911SR24C0030). This award is comprised primarily of oral TPOXX®, with a small a...
Neutral
Seeking Alpha
about one month ago
SIGA Technologies focuses on antiviral treatments, with its lead product TPOXX (tecovirimat) approved for smallpox and other orthopoxviruses. The PALM 007 study of tecovirimat in monkeypox patients failed to meet its primary endpoint but showed safety. SIGA's reliance on US government contracts, especially for TPOXX, introduces substantial revenue concentration risk.
More SIGA Technologies Inc News

Company Profile

SIGA Technologies, Inc. engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY.

Head office United States
CEO Diem Nguyen
Employees 45
Founded 1995
Website www.siga.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today